期刊文献+

重症肌无力患者血清补体成分的测定 被引量:2

Measurement of complements in the sera of patients with myasthenia gravis
暂未订购
导出
摘要 应用免疫单扩散法测定 5 5例重症肌无力 (MG)患者和 41例健康对照者血清中补体 (C1 q、C3 、C4、C9、C1 -INH因子、B因子 )的浓度。结果发现 ,MG患者 C1 -INH因子浓度明显高于健康对照组 (P<0 .0 0 1) ,而 C1 q和C9明显低于对照组 (P<0 .0 0 1) ;并且 ,随着受累肌群的增加 ,C1 q和 C9有降低的趋势 ,而 C1 -INH因子有升高趋势 ;其它补体成分的浓度与对照组相比无显著性差异 (P>0 .0 5 )。16例 MG初诊患者用药后 ,C9浓度显著升高 (P<0 .0 0 1) ,C1 q增高趋势及 C1 -INH因子下降趋势均明显 ,但三者均未恢复至正常水平 (P<0 .0 1)。提示对 MG患者测定血清补体 ,有助于进行动态观察 ,并可作为判断病情严重程度 (活动性 ) By using immune simple diffuse,the levels of the complements(C 1q ?C 3?C 4?C 9?C 1 INH factor?Bf)were measured in the sera from 55 MG patients and 41 controls Concentrations of C 9 and C 1q in MG patients were much lower than these in controls,while the concentration of C 1 INH rose significantly(P<0 001) With more skeletal muscles affected,both the tendency of the decline of C 9 and C 1q and that of the elevation of C 1 INH were more obvious The difference of the concentrations of the other complements between MG patients and controls had no statistical significance The levels of complements in the sera of 16 MG patients were also measured dynamically The concentration of C 9 significantly elevated after immune treatment(P<0 001),while the tendency of the decline of C 1 INH and the elevation of C 1q was obvious,all of them were not normal yet The test suggests that defecting of the levels of the complements in MG patients has attributions to mobile MG and maybe an objective index in determing the disease severity
出处 《山东医药》 CAS 北大核心 2002年第14期11-13,共3页 Shandong Medical Journal
关键词 重症肌无力 血清 补体成分 测定 Myasthenia Gravis Sera Complements
  • 相关文献

参考文献3

二级参考文献3

  • 1涂来慧,中华神经精神科杂志,1983年,4期,250页
  • 2沈茜,中华医学检验杂志,1987年,10期,214页
  • 3郭峰,上海免疫学杂志,1982年,2期,32页

共引文献2

同被引文献14

  • 1孙彦,王琪.2002年AJCC喉癌分期方案[J].国外医学(耳鼻咽喉科学分册),2004,28(4):248-249. 被引量:22
  • 2凌华.补体与肿瘤发展的关系[J].国外医学(生理病理科学与临床分册),1993,13(1):14-15. 被引量:1
  • 3郝中顺,楼觉人.重症肌无力病人血清中补体成份的测定[J].中华神经精神科杂志,1989,22(3):141-143. 被引量:2
  • 4余华葵 吴慧君 等.重症肌无力病人血清中补体成分的变化[J].华西医科大学学报,1991,22(4):438-438.
  • 5Gendek-Kubiak H, Grzegorczyk J, Gendek EG, et al. Pre-operative levels of serum immunoglobulins, circulating immune complexes and complement proteins in patients with different types of neoplasms[J]. Arch Immunol Ther Exp (Warsz), 2001, 49( Suppl 2):S89.
  • 6Lavedan P, Savage E, Lee Y, et al. Circulating C1q-binding macromolecles and their relationship to radiographic characteristics of laryngeal cancer[J]. Arch Otolaryngol Head Neck Surg, 1991, 117(3):292.
  • 7Fujita T, Hara A, Yamazaki Y. The value of acute-phase protein ments after curative gastric cancer surgery[J] . Arch Surg, 1999, 134(1):73.
  • 8Fredrik R,Kristoffersen K,Johan A,et al.The role of complement in myasthenia gravis:serological evidence of complement consumption in vivo[J].Neuroimmunology,2005,158:191-194.
  • 9周新涛,李绍英.补体系统与缺血性脑血管病[J].国外医学(脑血管疾病分册),2000,8(1):12-15. 被引量:5
  • 10吴桂荣,庄永敬,王俊津,吴小超.血清总补体水平与肝癌病理类型关系[J].肿瘤研究与临床,2000,12(4):235-236. 被引量:1

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部